Hans Naver

1.9k total citations
28 papers, 1.4k citations indexed

About

Hans Naver is a scholar working on Physiology, Neurology and Cell Biology. According to data from OpenAlex, Hans Naver has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 13 papers in Neurology and 6 papers in Cell Biology. Recurrent topics in Hans Naver's work include Sympathectomy and Hyperhidrosis Treatments (15 papers), Botulinum Toxin and Related Neurological Disorders (10 papers) and Myofascial pain diagnosis and treatment (6 papers). Hans Naver is often cited by papers focused on Sympathectomy and Hyperhidrosis Treatments (15 papers), Botulinum Toxin and Related Neurological Disorders (10 papers) and Myofascial pain diagnosis and treatment (6 papers). Hans Naver collaborates with scholars based in Sweden, United States and Austria. Hans Naver's co-authors include B. Gunnar Wallin, Christian Blomstrand, C. Swartling, Carl Swartling, Magnus Lindberg, Sten‐Magnus Aquilonius, Nicholas J. Lowe, Samuel S. Ahn, John Hornberger and Kevin Grimes and has published in prestigious journals such as The Journal of Physiology, Stroke and Journal of the American Academy of Dermatology.

In The Last Decade

Hans Naver

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Naver Sweden 20 831 436 273 179 169 28 1.4k
Franco Gemignani Italy 27 396 0.5× 1.2k 2.7× 137 0.5× 223 1.2× 48 0.3× 78 2.0k
Renato J. Verdugo Chile 18 597 0.7× 268 0.6× 89 0.3× 105 0.6× 36 0.2× 40 1.3k
Mayienne Bakkers Netherlands 15 779 0.9× 856 2.0× 94 0.3× 45 0.3× 25 0.1× 16 1.5k
Sally A. Waterman Australia 22 672 0.8× 191 0.4× 199 0.7× 18 0.1× 60 0.4× 31 1.5k
A Marbini Italy 19 256 0.3× 589 1.4× 92 0.3× 174 1.0× 43 0.3× 50 1.1k
Detlef Claus Germany 18 162 0.2× 410 0.9× 58 0.2× 151 0.8× 123 0.7× 27 1.0k
V. Scaioli Italy 23 154 0.2× 604 1.4× 199 0.7× 198 1.1× 18 0.1× 78 1.5k
Nanna Witting Denmark 24 422 0.5× 311 0.7× 57 0.2× 140 0.8× 396 2.3× 81 1.5k
Manabu Sakuta Japan 17 213 0.3× 286 0.7× 53 0.2× 155 0.9× 80 0.5× 53 927
A. Biasiotta Italy 23 737 0.9× 691 1.6× 26 0.1× 151 0.8× 33 0.2× 44 1.5k

Countries citing papers authored by Hans Naver

Since Specialization
Citations

This map shows the geographic impact of Hans Naver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Naver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Naver more than expected).

Fields of papers citing papers by Hans Naver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Naver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Naver. The network helps show where Hans Naver may publish in the future.

Co-authorship network of co-authors of Hans Naver

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Naver. A scholar is included among the top collaborators of Hans Naver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Naver. Hans Naver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salzer, Jonatan, Jan Lycke, Ronny Wickström, et al.. (2015). Rituximab in paediatric onset multiple sclerosis: a case series. Journal of Neurology. 263(2). 322–326. 46 indexed citations
2.
Bertilsson, Maria, et al.. (2013). Effect of Botulinum Toxin Concentration on Reduction in Sweating: A Randomized, Double-blind Study. Acta Dermato Venereologica. 93(6). 674–678. 17 indexed citations
3.
Nyholm, Dag, et al.. (2012). Clinical Experience of Dose Conversion Ratios Between 2 Botulinum Toxin Products in the Treatment of Cervical Dystonia. Clinical Neuropharmacology. 35(6). 278–282. 16 indexed citations
4.
Swartling, Carl, et al.. (2012). [Hyperhidrosis--the "silent" handicap].. PubMed. 108(47). 2428–32. 3 indexed citations
5.
Enroth, Sofia Bosdotter, et al.. (2010). Bilateral forearm intravenous regional anesthesia with prilocaine for botulinum toxin treatment of palmar hyperhidrosis. Journal of the American Academy of Dermatology. 63(3). 466–474. 10 indexed citations
6.
Swartling, Carl, et al.. (2008). Anhidrotic Effect of Intradermal Injections of Botulinum Toxin: A Comparison of Different Products and Concentrations. Acta Dermato Venereologica. 88(3). 229–233. 16 indexed citations
7.
Swartling, C., et al.. (2008). Equipotent Concentrations of Botox® and Dysport® in the Treatment of Palmar Hyperhidrosis. Acta Dermato Venereologica. 88(5). 458–461. 22 indexed citations
8.
Swartling, Carl, Hans Naver, Inger Pihl-Lundin, Eva Hagforsen, & Anders Vahlquist. (2004). Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin. Journal of the American Academy of Dermatology. 51(5). 739–745. 36 indexed citations
9.
Hornberger, John, Kevin Grimes, Markus Naumann, et al.. (2004). Recognition, diagnosis, and treatment of primary focal hyperhidrosis. Journal of the American Academy of Dermatology. 51(2). 274–286. 311 indexed citations
10.
Swartling, Carl, et al.. (2002). Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. Journal of the American Academy of Dermatology. 47(5). 667–671. 59 indexed citations
11.
Swartling, C., Hans Naver, & Magnus Lindberg. (2001). Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. European Journal of Neurology. 8(3). 247–252. 98 indexed citations
12.
Swartling, Carl, et al.. (2001). Side‐effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. European Journal of Neurology. 8(5). 451–456. 50 indexed citations
13.
Naver, Hans, C. Swartling, & Sten‐Magnus Aquilonius. (2000). Palmar and axillary hyperhidrosis treated with botulinum toxin: one‐year clinical follow‐up. European Journal of Neurology. 7(1). 55–62. 85 indexed citations
15.
Tarkowski, E., Hans Naver, B. Gunnar Wallin, et al.. (1996). Lateralization of cutaneous inflammatory responses in patients with unilateral paresis after poliomyelitis. Journal of Neuroimmunology. 67(1). 1–6. 19 indexed citations
16.
Naver, Hans. (1996). Dysfunction of the autonomic nervous system after stroke. Gothenburg University Publications Electronic Archive (Gothenburg University). 2 indexed citations
17.
Tarkowski, E., Hans Naver, B. Gunnar Wallin, Christian Blomstrand, & A Tarkowski. (1994). Lateralization of T-lymphocyte responses in patients with stroke: Effect of sympathetic dysfunction?. Journal of Neuroimmunology. 54(1-2). 201–201. 1 indexed citations
18.
Wårdell, Karin, Hans Naver, Gert Nilsson, & B. Gunnar Wallin. (1993). The cutaneous vascular axon reflex in humans characterized by laser Doppler perfusion imaging.. The Journal of Physiology. 460(1). 185–199. 99 indexed citations
19.
Naver, Hans, Lars‐Erik Augustinsson, & Mikael Elam. (1992). The vasodilating effect of spinal dorsal column stimulation is mediated by sympathetic nerves. Clinical Autonomic Research. 2(1). 41–45. 21 indexed citations
20.
Hornyak, Magdolna, Hans Naver, Bertil Rydenhag, & B. Gunnar Wallin. (1990). Sympathetic activity influences the vascular axon reflex in the skin. Acta Physiologica Scandinavica. 139(1-2). 77–84. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026